GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Shionogi & Co Ltd (TSE:4507) » Definitions » EV-to-EBIT

Shionogi (TSE:4507) EV-to-EBIT : 7.91 (As of Apr. 26, 2024)


View and export this data going back to 1949. Start your Free Trial

What is Shionogi EV-to-EBIT?

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Shionogi's Enterprise Value is 円1,549,914 Mil. Shionogi's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was 円195,986 Mil. Therefore, Shionogi's EV-to-EBIT for today is 7.91.

The historical rank and industry rank for Shionogi's EV-to-EBIT or its related term are showing as below:

TSE:4507' s EV-to-EBIT Range Over the Past 10 Years
Min: 4.86   Med: 11.26   Max: 20.67
Current: 7.91

During the past 13 years, the highest EV-to-EBIT of Shionogi was 20.67. The lowest was 4.86. And the median was 11.26.

TSE:4507's EV-to-EBIT is ranked better than
80.3% of 670 companies
in the Drug Manufacturers industry
Industry Median: 17.115 vs TSE:4507: 7.91

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %. Shionogi's Enterprise Value for the quarter that ended in Dec. 2023 was 円1,497,764 Mil. Shionogi's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was 円195,986 Mil. Shionogi's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2023 was 13.09%.


Shionogi EV-to-EBIT Historical Data

The historical data trend for Shionogi's EV-to-EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shionogi EV-to-EBIT Chart

Shionogi Annual Data
Trend Mar14 Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23
EV-to-EBIT
Get a 7-Day Free Trial Premium Member Only Premium Member Only 10.15 7.72 9.74 14.39 5.46

Shionogi Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
EV-to-EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 5.94 5.46 5.13 5.25 7.64

Competitive Comparison of Shionogi's EV-to-EBIT

For the Drug Manufacturers - Specialty & Generic subindustry, Shionogi's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Shionogi's EV-to-EBIT Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Shionogi's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Shionogi's EV-to-EBIT falls into.



Shionogi EV-to-EBIT Calculation

Shionogi's EV-to-EBIT for today is calculated as:

EV-to-EBIT=Enterprise Value (Today)/EBIT (TTM)
=1549913.792/195986
=7.91

Shionogi's current Enterprise Value is 円1,549,914 Mil.
Shionogi's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was 円195,986 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Shionogi  (TSE:4507) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

Shionogi's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2023 is calculated as:

Earnings Yield (Joel Greenblatt) % (Q: Dec. 2023 ) =EBIT / Enterprise Value (Q: Dec. 2023 )
=195986/1497763.734
=13.09 %

Shionogi's Enterprise Value for the quarter that ended in Dec. 2023 was 円1,497,764 Mil.
Shionogi's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was 円195,986 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Shionogi EV-to-EBIT Related Terms

Thank you for viewing the detailed overview of Shionogi's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.


Shionogi (TSE:4507) Business Description

Traded in Other Exchanges
Address
1-8, Doshomachi 3-chome, Chuo-ku, Osaka, JPN, 541-0045
Shionogi & Co Ltd is a specialty and generic drug manufacturing company. The company focuses on the manufacturing and distribution of pharmaceuticals, diagnostic reagents, and medical devices. Shionogi engages in manufacturing, formulation, packaging, and analysis as part of its commercialization research that spans late stage drug discovery through commercial production. The company's research and development strategy utilizes partnership and licensing opportunities with academic constituents and venture companies.

Shionogi (TSE:4507) Headlines

No Headlines